COMBINATION BRAF AND MEK INHIBITOR THERAPY FOR REDIFFERENTIATION OF RADIOIODINE REFRACTORY BRAF MUTATED PAPILLARY THYROID CANCER: A CASE STUDY

被引：0
|
作者：
Daw, N. [1 ]
Iravani, A. [1 ,2 ]
机构：
[1] Peter Maccallum Canc Ctr, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [1] Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
    Jafri, Sabih
    Yaqub, Abid
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [2] HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
    Cheng, Lingxiao
    Jin, Yuchen
    Liu, Min
    Ruan, Maomei
    Chen, Libo
    [J]. ONCOTARGET, 2017, 8 (12) : 19843 - 19854
  • [3] BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study
    De Alcubierre, Dario
    Gkasdaris, Grigorios
    Mordrel, Margaux
    Joncour, Anthony
    Briet, Claire
    Almairac, Fabien
    Boetto, Julien
    Mouly, Celine
    Larrieu-Ciron, Delphine
    Vasiljevic, Alexandre
    Villa, Chiara
    Sergeant, Camille
    Ducray, Francois
    Feuvret, Loic
    Chanson, Philippe
    Baussart, Bertrand
    Raverot, Gerald
    Jouanneau, Emmanuel
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 191 (02) : 251 - 261
  • [4] Effect of the combination of radioiodine therapy and euthyrox in BRAF-mutated thyroid cancer post-total thyroidectomy
    Fu, Qiang
    Huang, Xueyang
    Yang, Yu
    Huang, Yalan
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (08) : 1353 - 1358
  • [5] BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer-A Case Series Study Target Therapy of BRAF-Mutated mCRC
    Yeh, Jen-Hao
    Tsai, Hsiang-Lin
    Chen, Yen-Cheng
    Li, Ching-Chun
    Huang, Ching-Wen
    Chang, Tsung-Kun
    Su, Wei-Chih
    Chen, Po-Jung
    Liu, Yu-Peng
    Wang, Jaw-Yuan
    [J]. MEDICINA-LITHUANIA, 2021, 57 (12):
  • [6] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Galliker, Nadja A.
    Murer, Carla
    Kamarashev, Jivko
    Dummer, Reinhard
    Goldinger, Simone M.
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (02) : 177 - 180
  • [7] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Nadja A. Galliker
    Carla Murer
    Jivko Kamarashev
    Reinhard Dummer
    Simone M. Goldinger
    [J]. European Journal of Dermatology, 2015, 25 : 177 - 180
  • [8] BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary Thyroid Cancer
    Groener, Jan Benedikt
    Gelen, Debora
    Mogler, Carolin
    Herpel, Esther
    Toth, Csaba
    Kender, Zoltan
    Peichl, Marco
    Haufe, Sabine
    Haberkorn, Uwe
    Sulaj, Alba
    Zemva, Johanna
    Kopf, Stefan
    Nawroth, Peter Paul
    Brune, Maik
    Rudofsky, Gottfried
    [J]. HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 69 - 75
  • [9] Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
    Rothenberg, S. Michael
    McFadden, David G.
    Palmer, Edwin L.
    Daniels, Gilbert H.
    Wirth, Lori J.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (05) : 1028 - 1035
  • [10] BRAF and MEK inhibitor combination therapy-related eye AEs
    [J]. Reactions Weekly, 2023, 1948 (1) : 10 - 10
12345